Print

Invitrogen Corporation (IVGN) Launches Benchtop Device That Simplifies Primary and Stem Cell Research  
3/24/2009 9:32:47 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today announced the launch of the Neon Transfection Device, a bench-top tool that enables researchers to better understand the functions of cells, genes and proteins. This device simplifies the delivery of DNA, RNA, and proteins into a wide range of mammalian cell types, especially difficult to transfect cells, such as many types of primary and stem cells.
//-->